CLINICAL_TRIALS
trial_result
· 2008-01-18
Clinical Trial Update: Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults [Phase 1]
Summary
A Phase 1 trial assesses the safety and immune response of the rDEN1delta30 dengue vaccine in healthy adults.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dengue Fever | Phase 1 | Status: COMPLETED